Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis
-
By
-
Beni Matangi
-
Placide Matondo
-
Brandon Kayembe
-
Axel Okolo
-
Dieudonné Tawaba
-
Amede Kinuka
-
Donat Mangala
-
Ossam Odio
-
Nadine Mayasi
-
Tuna Lukiana
-
Madone Mandina
-
Taylor Pindi
-
Murielle Longokolo
-
Marcel Mbula
-
Hippolyte Situakibanza
-
Ben Bepouka
-
February 6, 2026
Clinical Scorecard: Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis
At a Glance
| Category | Detail |
|---|
| Condition | Ebola Virus Disease (EVD) |
| Key Mechanisms | Transmission through direct contact with infected fluids; vaccination as a preventive measure. |
| Target Population | Individuals or communities residing in sub-Saharan Africa. |
| Care Setting | Public health and vaccination campaigns. |
Key Highlights
- EVD has a high case-fatality rate averaging around 50%.
- Vaccine hesitancy is a major barrier to achieving optimal vaccination coverage.
- Two vaccines are licensed for EVD prevention: Ad26.ZEBOV/MVA-BN-Filo and rVSVΔG-ZEBOV-GP.
- Determinants of vaccine acceptability include sociodemographic factors and trust in health authorities.
- Acceptability rates vary significantly across different studies and settings.
Guideline-Based Recommendations
Diagnosis
- Assess willingness to receive the Ebola vaccine through surveys.
Management
- Implement targeted interventions to improve vaccine acceptance.
Monitoring & Follow-up
- Track vaccination rates and public perception of vaccine safety and efficacy.
Risks
- Address misinformation and distrust that contribute to vaccine hesitancy.
Patient & Prescribing Data
Sub-Saharan African communities at risk of EVD.
Vaccination is crucial for preventing EVD outbreaks.
Clinical Best Practices
- Engage community leaders to build trust in vaccination efforts.
- Utilize the WHO's '3Cs' model to address vaccine hesitancy.
- Provide clear and accessible information about vaccine safety and efficacy.
Related Resources & Content
